These previous observations strongly support our hypothesis that both IL7 and MAL2 play essential roles in HCC drug resistance by dysregulating JAK/STAT and PI3K/AKT signaling pathways. This evidence concerns the gene SOAT1 and hepatocellular carcinoma.